Terns Pharmaceuticals, Inc.

TERN · Nasdaq · SIC 2834: Pharmaceutical Preparations
99
SEC Filings

Business Summary

PART I . Pending Acquisition by Merck Sharp & Dohme LLC On March 24, 2026, we entered into an Agreement and Plan of Merger (the Merger Agreement) by and among us, Merck Sharp & Dohme LLC, a New Jersey limited liability company (Parent), and Thailand Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (Purchaser). Pursuant to the Merger Agreement, upon the terms and subject to the conditions thereof, Parent will cause Purchaser to commence a tender offer (the Offer) to ...

Next Earnings

Q2 FY2026 — expected 2026-08-08

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTERNdiscussed_in_filing Cybersecurity
topic_mentionTERNdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001193125-26-131828EDGAR100K words
2025-03-202024-12-310000950170-25-042695EDGAR—
2024-03-142023-12-310000950170-24-031497EDGAR—
2023-03-272022-12-310000950170-23-010016EDGAR—
2022-03-072021-12-310000950170-22-002962EDGAR—
2021-03-302020-12-310001564590-21-016734EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-274367EDGAR25K words
2025-08-052025-06-300000950170-25-103124EDGAR—
2025-05-082025-03-310000950170-25-067003EDGAR—
2024-11-122024-09-300000950170-24-125584EDGAR—
2024-08-052024-06-300000950170-24-090925EDGAR—
2024-05-132024-03-310000950170-24-058672EDGAR—
2023-11-142023-09-300000950170-23-063380EDGAR—
2023-08-082023-06-300000950170-23-039927EDGAR—
2023-05-152023-03-310000950170-23-021995EDGAR—
2022-11-092022-09-300000950170-22-023982EDGAR—
2022-08-082022-06-300000950170-22-015561EDGAR—
2022-05-162022-03-310000950170-22-010118EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-250001193125-26-122785EDGAR47K words
2026-01-220001193125-26-019426EDGAR—
2026-01-090001193125-26-008907EDGAR—
2025-12-110001193125-25-315065EDGAR—
2025-12-080001193125-25-311202EDGAR—
2025-11-100001193125-25-274282EDGAR—
2025-11-030001193125-25-261798EDGAR—
2025-10-220001193125-25-245404EDGAR—
2025-08-050000950170-25-103071EDGAR—
2025-06-160000950170-25-086758EDGAR—

99 total filings indexed. 71 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001831363
TickerTERN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 9246aed8477d5fa8b4fb7938381524c2f4237aec80cf7e60faf6a4a4c6da40f2
parent: 8c4ba5955a16b7f274b96013a1a655438dbd033ceea8dc1854d9a287fc108bdf
content hash: bb7b1f16ad3279210f298b4822aaa747db83914c2b6227f710e37198635a065d
signed: 2026-04-13T04:47:46.206Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf